Management of chronic myelogenous leukemia.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000648:ultrastructure; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007370:Interferon Type I / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D010677:Philadelphia Chromosome; D011519:Proto-Oncogenes; D011994:Recombinant Proteins / Q000627:therapeutic use; D013156:Splenectomy; D014178:Translocation, Genetic
D007370:Interferon Type I; D011994:Recombinant Proteins; D002066:Busulfan; D006918:Hydroxyurea